Afsheen Banisadr, PhD, is a Scientist 2 at Entos, Inc. Currently, Afsheen is focused on cancer diagnostics and therapeutics with a translational research focus. Prior to their current role, Afsheen worked at Turning Point Therapeutics and Ludwig Cancer Research as a Doctoral Candidate. Their educational background includes a Ph.D. in Biological and Biomedical Sciences from UC San Diego and a Honors Bachelor of Science in Biomedical/Medical Engineering from the University of Utah.
June, 2022 - present